Aytu Biopharma Inc
AYTU2.390USD
+0.090+3.91%
Handelsschluss 02/06, 16:00（ET）Kurse um 15 Minuten verzögert
23.69MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Aytu Biopharma Inc Unternehmen
Aytu BioPharma, Inc. is a pharmaceutical company focused on commercializing novel therapeutics. The Company's business is focused on its prescription pharmaceutical products sold primarily through third party wholesalers and pharmacies and which primarily consists of two product portfolios. The first consists of two products for the treatment of ADHD: Adzenys XR-ODT (amphetamine) extended-release orally disintegrating tablets (Adzenys) and Cotempla XR-ODT (methylphenidate) extended-release orally disintegrating tablets. The second consists primarily of Karbinal ER (carbinoxamine maleate extended-release oral suspension), an extended-release first-generation antihistamine suspension containing carbinoxamine indicated to treat numerous allergic conditions, and Poly-Vi-Flor and Tri-Vi-Flor, two complementary prescription fluoride-based supplement product lines containing combinations of fluoride and vitamins in various formulations for infants and children with fluoride deficiency.
Aytu Biopharma Inc Informationen
BörsenkürzelAYTU
Name des UnternehmensAytu Biopharma Inc
IPO-datumOct 20, 2017
CEODisbrow (Joshua R)
Anzahl der mitarbeiter82
WertpapierartOrdinary Share
GeschäftsjahresendeOct 20
Addresse7900 E. Union Avenue
StadtDENVER
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl80237
Telefon17204376580
Websitehttps://aytubio.com/
BörsenkürzelAYTU
IPO-datumOct 20, 2017
CEODisbrow (Joshua R)
Führungskräfte von Aytu Biopharma Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Jarrett T. (Josh) Disbrow
Mr. Jarrett T. (Josh) Disbrow
Chief Business Officer
Chief Business Officer
61.57K
+32106.00%
Mr. Ryan J. Selhorn, CPA
Mr. Ryan J. Selhorn, CPA
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
49.74K
+33743.00%
Mr. Greg Pyszczymuka
Mr. Greg Pyszczymuka
Chief Commercial Officer
Chief Commercial Officer
36.10K
+12291.00%
Mr. Carl C. Dockery
Mr. Carl C. Dockery
Independent Director
Independent Director
21.15K
+10000.00%
Ms. Vivian H. Liu
Ms. Vivian H. Liu
Independent Director
Independent Director
19.82K
+10000.00%
Mr. Joshua R. (Josh) Disbrow
Mr. Joshua R. (Josh) Disbrow
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. John A. Donofrio, Jr.
Mr. John A. Donofrio, Jr.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Abhinav (Abi) Jian
Mr. Abhinav (Abi) Jian
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Jarrett T. (Josh) Disbrow
Mr. Jarrett T. (Josh) Disbrow
Chief Business Officer
Chief Business Officer
61.57K
+32106.00%
Mr. Ryan J. Selhorn, CPA
Mr. Ryan J. Selhorn, CPA
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
49.74K
+33743.00%
Mr. Greg Pyszczymuka
Mr. Greg Pyszczymuka
Chief Commercial Officer
Chief Commercial Officer
36.10K
+12291.00%
Mr. Carl C. Dockery
Mr. Carl C. Dockery
Independent Director
Independent Director
21.15K
+10000.00%
Ms. Vivian H. Liu
Ms. Vivian H. Liu
Independent Director
Independent Director
19.82K
+10000.00%
Mr. Joshua R. (Josh) Disbrow
Mr. Joshua R. (Josh) Disbrow
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
ADHD portfolio
13.16M
94.73%
Pediatric portfolio
715.00K
5.15%
Other
17.00K
0.12%
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
ADHD portfolio
13.16M
94.73%
Pediatric portfolio
715.00K
5.15%
Other
17.00K
0.12%
Aktionärsstatistik
Aktualisiert: Fri, Feb 6
Aktualisiert: Fri, Feb 6
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Nantahala Capital Management, LLC
10.13%
Stonepine Capital Management, LLC
8.31%
AWM Investment Company, Inc.
5.77%
The Vanguard Group, Inc.
2.60%
Diadema Partners LP
2.54%
Andere
70.66%
Aktionäre
Aktionäre
Anteil
Nantahala Capital Management, LLC
10.13%
Stonepine Capital Management, LLC
8.31%
AWM Investment Company, Inc.
5.77%
The Vanguard Group, Inc.
2.60%
Diadema Partners LP
2.54%
Andere
70.66%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor/Hedge Fund
15.55%
Hedge Fund
15.19%
Individual Investor
5.13%
Investment Advisor
3.26%
Bank and Trust
0.03%
Andere
60.84%
Institutionelle Beteiligung
Aktualisiert: Mon, Dec 8
Aktualisiert: Mon, Dec 8
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
61
3.62M
34.64%
--
2025Q3
63
3.62M
35.61%
+200.00K
2025Q2
63
3.42M
23.61%
+1.37M
2025Q1
58
1.88M
32.85%
-147.25K
2024Q4
61
1.88M
35.64%
-167.56K
2024Q3
65
2.05M
38.87%
-5.48K
2024Q2
68
2.06M
35.52%
+258.31K
2024Q1
72
1.80M
39.85%
-420.62K
2023Q4
75
1.77M
40.04%
+44.24K
2023Q3
81
1.73M
39.72%
+20.75K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Nantahala Capital Management, LLC
1.09M
10.67%
--
--
Sep 30, 2025
Stonepine Capital Management, LLC
891.86K
8.75%
+79.18K
+9.74%
Sep 30, 2025
AWM Investment Company, Inc.
619.57K
6.08%
-300.00
-0.05%
Sep 30, 2025
The Vanguard Group, Inc.
278.58K
2.73%
+250.69K
+898.94%
Sep 30, 2025
Diadema Partners LP
272.67K
2.68%
+272.67K
--
Sep 30, 2025
Disbrow (Joshua R.)
207.20K
2.03%
+53.95K
+35.20%
Oct 13, 2025
Lytton (Laurence W)
122.06K
1.2%
-384.54K
-75.91%
Sep 30, 2025
Two Sigma Investments, LP
108.54K
1.07%
+73.50K
+209.79%
Sep 30, 2025
Renaissance Technologies LLC
95.12K
0.93%
+5.21K
+5.79%
Sep 30, 2025
Geode Capital Management, L.L.C.
71.01K
0.7%
+17.14K
+31.81%
Sep 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Dimensional US Core Equity 1 ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
Dimensional US Core Equity 1 ETF
Anteil0%
DFA Dimensional US Sustainability Core 1 ETF
Anteil0%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Ex-Dividendentag
Art
Verhältnis
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Dec 08, 2020
Merger
10→1
Dec 08, 2020
Merger
10→1
Datum
Ex-Dividendentag
Art
Verhältnis
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Dec 08, 2020
Merger
10→1
Dec 08, 2020
Merger
10→1
Dec 08, 2020
Merger
10→1
Dec 08, 2020
Merger
10→1
